MARCEL DEKKER, INC. • 270 MADISON AVENUE • NEW YORK, NY 10016
©2002 Marcel Dekker, Inc. All rights reserved. This material may not be used or reproduced in any form without the express written permission of Marcel Dekker, Inc.
Pure Alkylated D-Erythritols and D-Threitols
43
97.0 (C-1a), 80.9, 79.9 (C-3a, C-3b), 78.7 (C-2), 74.4, 70.4 (C-4a, C-4b), 73.5 (2CH2–
Ph), 71.4 (C-a(a)), 71.2 (C-a(b)), 70.0 (C-5b), 69.7 (C-5a), 31.7 !22.5 (CH2 alkyl
chain), 14.0 (C-o).
2-O-n-Alkyl-4-O-benzyl-D-erythritols (9a,c). Compounds 8a,c were subjected to
NaIO4 oxidative degradation and subsequent reduction under the conditions used for 5.
The desired products were isolated after purification by column chromatography (Table
1
1). H NMR (CDCl3) of 9c d 7.32 !7.23 (Ph), 4.56 (d, 1H, Ja,b 11.8 Hz, H-b (CH2–
Ph)), 4.51 (d, 1H, H-a (CH2–Ph)), 3.88 (m, 1H, J2,3 = 6.9 Hz, H-3), 3.79 ! 3.69 (m, 2H,
H-1a, H-1b), 3.63 (dd, 1H, J4a,4b = 9.3 Hz, J3,4b = 3.6 Hz, H-4b), 3.56 (dd, 1H, H-4a),
3.51 (dt, 1H, Ja,b = 6.7 Hz, H-a’), 3.40 (dt, 1H, Ja,a’ = 9.3 Hz, H-a), 3.32 (m, 1H, H-2),
1.52 !1.23 (CH2 alkyl chain), 0.85 (t, 3H, Jo,o ꢀ 1 = 6.6 Hz, H-o). 13C NMR (CDCl3)
of 9c d 137.7, 128.4, 127.8, 127.8 (Ph), 79.2 (C-2), 73.4 (CH2–Ph), 70.9 (C-4), 70.7 (C-3),
70.5 (C-a), 61.4 (C-1), 31.8 !22.6 (CH2 alkyl chain), 14.0 (C-o).
2-O-n-Alkyl-D-erythritols (10a,c). Compounds 9a,c were debenzylated under the
conditions used for 7. The desired products were isolated by crystallization of the crude
product from diethyl ether (Table 1). 1H NMR (C5D5N) of 10c d 4.24 (m, 1H,
J3,4b = 4.5 Hz, H-3), 4.18 !4.11 (m, 2H, H-1a, H-1b), 4.08 (dd, 1H, J4a,4b = 11.0 Hz,
H-4b), 4.03 (dd, 1H, J3,4a = 6.2 Hz, H-4a), 3.73 ! 3.66 (m, 2H, H-2, H-a’), 3.65 (dt,
1H, Ja,a’ = 9.3 Hz, H-a), 1.60 !1.18 (m, CH2 alkyl chain), 0.83 (t, 3H, Jo,o ꢀ 1 = 6.6
Hz, H-o). 13C NMR (C5D5N) of 10c d 82.6 (C-2), 73.4 (C-3), 71.2 (C-a), 64.9 (C-4),
62.5 (C-1), 32.5 !23.3 (CH2 alkyl chain), 14.7 (C-o).
1,2-O-Isopropylidene-5-O-n-alkyl- -D-ribofuranoses (11a,c). 5-O-n-Alkyl-1,
2-O-isopropylidene-a-D-xylofuranose (2a–c)[7] was oxidized and then reduced under
the conditions used for 3. The desired product was isolated after purification by column
1
chromatography (Table 1). H NMR (CDCl3) of 11a d 5.78 (d, 1H, J1,2 = 3.9 Hz, H-
1), 4.51 (d, 1H, J2,3 = 4.2 Hz, H-2), 3.88 (m, 1H, J3,4 = 4.0 Hz, H-4), 3.85 (m, 2H,
J4,5a = 4.4 Hz, J4,5b = 2.3 Hz, J5a,5b = 10.9 Hz, H-5a, H-5b), 3.45 (dt, 1H,
Jaa’,bb’ = 5.1 Hz, H-a’), 3.41 (dt, 1H, Ja,a’ = 9.3 Hz, H-a), 1.56 ! 1.22 (CH2 alkyl
chain),), 0.83 (t, 3H, Jo,o ꢀ 1 = 6.7 Hz, H-o). 13C NMR (CDCl3) of 11a d 112.5
(CMe2), 104.1 (C-1), 79.7 (C-4), 78.3 (C-2), 71.9 (C-a), 71.7 (C-3), 69.2 (C-5),
31.7 !22.5 (CH2 alkyl chain), 26.4 (CMe2), 14.0 (C-o).
5-O-n-Dodecyl-D-ribofuranose (12c). Compound 11c (5 g, 14 mmol) was
deprotected under the conditions used for 4. After extraction and concentration, the
crude product was recrystallized in 2:1 hexane–acetone (4.1 g, 92%); a/b = 1/3, mp
1
60°C, [a]D ꢀ 8° (c 0.6, C5H5N). H NMR (C5D5N) d 5.96 (s, 1H, H-1b), 5.79 (s, 1H,
H-1a), 4.77 (m, 1H, J2b,3b = 4.6 Hz, J3b,4b = 5.5 Hz, H-3b), 4.70 (m, 1H, J4b,5ab = 6.3
Hz, H-4b), 4.59 (d, 1H, H-2b), 4.46 (d, 1H, J2a,3a = 4.5 Hz, H-2a), 3.99 (dd, 1H,
J4b,5bb = 3.2 Hz, H-5bb), 3.90 (dd, 1H, J5ab,5bb = 10.3 Hz, H-5ab), 3.78 (dd, 1H,
J5aa,5ba = 10.6 Hz, H-5ba), 3.70 (dd, 1H, J4a,5aa = 4.7 Hz, H-5aa), 3.57 ! 3.44 (m, H-a),
1.59 !1.19 (m, CH2 alkyl chain), 0.83 (t, 3H, Jo,o ꢀ 1 = 6.3 Hz, H-o). 13C NMR
(C5D5N) d 102.4 (C-1b), 96.8 (C-1a), 81.7 (C-4b), 76.0 (C-2b), 73.0 (C-5b), 72.0 (C-3b),
71.2 (C-2a), 71.0 (C-5a), 70.6 (C-a), 31.0 ! 21.8 (CH2 alkyl chain), 13.2 (C-o).
Anal. Calcd for C17H34O5 (318.46): C, 64.12; H, 10.76. Found: C, 64.28; H, 10.89.